Growing Concerns About Increased Recreational Use of Ketamine in the UK
Medical professionals warn of a rising trend in recreational ketamine use in the UK, highlighting serious health risks and the need for better treatment and regulation. Learn about the ongoing concerns and potential solutions.
Recent reports from medical professionals highlight a troubling rise in the recreational use of ketamine across the United Kingdom. Originally developed and widely used as a medical anesthetic, ketamine is also prescribed at lower doses for managing chronic pain, treatment-resistant depression, and suicidality, with intranasal esketamine approved for depression treatment. However, the low cost and easy availability of ketamine have led to its growing popularity among young individuals engaging in non-prescribed use.
Medical experts from the British Medical Journal warn that this trend poses significant health risks. High doses used recreationally can lead to irreversible damage to vital organs such as the bladder and kidneys, alongside severe psychiatric issues including hallucinations and cognitive disturbances. The increase in recreational use has also resulted in a spike in addiction treatment admissions, with 3,609 individuals seeking help in 2023-24—more than eight times the number reported a decade earlier.
Despite these concerns, ketamine use disorders are still inadequately defined within psychiatric guidelines, and there is limited evidence for effective treatment options. Healthcare providers often lack understanding about ketamine addiction, leading to minimal tailored treatment strategies, which hampers successful recovery.
The challenge lies in balancing ketamine’s legitimate medical utility against its potential for abuse. Some policymakers suggest reclassifying ketamine as a controlled substance Class A, yet opinions differ on the best course of action. Experts advocate for a comprehensive approach that includes stronger governance over therapeutic use, increased investment in prevention and treatment services, and balanced public messaging to address the complex issue.
This trend underscores the need for improved public awareness about the long-term harms of recreational ketamine use and the development of better diagnostic and intervention tools to combat its misuse.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding Why Preventive Mastectomy Isn't Accessible to All at-Risk Individuals
Preventive mastectomy can save lives but remains unevenly accessible, with disparities based on genetic risk factors. Learn why medical equity in breast cancer prevention is essential.
Improving Reading Speed in Children with Dyslexia Through Sensory-Motor Activities
A novel sensorimotor and cognitive intervention significantly boosts reading speed and self-esteem in children with dyslexia, offering promising benefits for early treatment strategies.
Medical Experts Explore Effective Treatments for Newly Identified Genetic Disorder VEXAS
Scientists have discovered VEXAS, a new age-related genetic disorder characterized by immune system inflammation due to acquired mutations in the UBA1 gene. Research is ongoing to develop effective treatments, including immunosuppressants and bone marrow transplants.
Herpes Simplex Virus-1 Infection Linked to Increased Alzheimer's Disease Risk
Emerging evidence suggests that herpes simplex virus-1 (HSV-1) infection may increase the risk of Alzheimer's disease, with antiviral therapy potentially offering protective benefits.